These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10509551)

  • 1. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension.
    Yasumoto K; Takata M; Ueno H; Tomita S; Tomoda F; Inoue H
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):921-4. PubMed ID: 10509551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy.
    Ogino K; Ogura K; Kinugawa T; Osaki S; Kato M; Furuse Y; Kinugasa Y; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Circ J; 2004 May; 68(5):444-50. PubMed ID: 15118286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma levels of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension].
    Kosmala W; Spring A
    Pol Merkur Lekarski; 2003 Mar; 14(81):216-9. PubMed ID: 12914098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin resistance in nondipper essential hypertensive patients.
    Anan F; Takahashi N; Ooie T; Yufu K; Saikawa T; Yoshimatsu H
    Hypertens Res; 2003 Sep; 26(9):669-76. PubMed ID: 14620920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
    Irzmanski R; Barylski M; Banach M; Piechota M; Kowalski J; Cierniewski C; Pawlicki L
    Med Sci Monit; 2007 Oct; 13(10):CR449-56. PubMed ID: 17901852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
    Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P
    J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes.
    Almeida S; Azevedo A; Castro A; Friões F; Freitas J; Ferreira A; Bettencourt P
    Cardiology; 2002; 98(3):113-5. PubMed ID: 12417808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yasunari K; Yokokawa K; Horio T; Kano H; Minami M; Ikeda M; Yoshikawa J
    Metabolism; 1996 Nov; 45(11):1326-9. PubMed ID: 8931634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
    Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
    Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
    Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of natriuretic peptides in patients suffering from idiopathic arterial hypertension and left ventricular diastolic dysfunction confirmed by echocardiography.
    Irzmański R; Pawlicki L; Charłusz M; Kowalski J
    Clin Exp Hypertens; 2012; 34(7):530-40. PubMed ID: 22783987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events.
    Suzuki M; Hamada M; Yamamoto K; Kazatani Y; Hiwada K
    Hypertens Res; 2002 Sep; 25(5):669-76. PubMed ID: 12452317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
    Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
    JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.